{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:19:09Z","timestamp":1759483149557,"version":"3.44.0"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2020,2,19]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                  <jats:title>Rationale<\/jats:title>\n                  <jats:p>Pulmonary non-tuberculous mycobacterial (PNTM) disease has increased over the past several decades, especially in older women. Abnormal mucociliary clearance and abnormal nasal nitric oxide (nNO) have been associated with PNTM disease in other patient cohorts. Mucociliary clearance can be affected by NO-cyclic guanosine monophosphate signalling and, therefore, modulation of the pathway may be possible with phosphodiesterase inhibitors such as sildenafil as a novel therapeutic approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To define ex vivo characteristics of PNTM disease affected by sildenafil.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Subjects with PNTM infections were recruited into an open-label dose-escalation trial of sildenafil. Laboratory measurements and mucociliary measurements\u2014ciliary beat frequency, nNO and 24-hour sputum production\u2014were collected throughout the study period. Patients received sildenafil daily during the study period, with escalation from 20 to 40 mg three times per day.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Measurements and main results<\/jats:title>\n                  <jats:p>Increased ciliary beat frequency occurred after a single dose of 40\u2009mg sildenafil and after extended dosing of 40\u2009mg sildenafil. The increase ciliary beat frequency was not seen with 20\u2009mg sildenafil dosing. There were no changes in sputum production, nNO production, Quality of Life-Bronchiectasis-NTM module (QOL-B-NTM) questionnaire or the St George\u2019s Respiratory Questionnaire during the study period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Sildenafil, 40\u2009mg, increased ciliary beat frequency acutely as well as with extended administration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2020-000574","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T05:20:35Z","timestamp":1584076835000},"page":"e000574","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I\/II trial"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct01853540","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00018044","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-0266","authenticated-orcid":false,"given":"Cedar","family":"Fowler","sequence":"first","affiliation":[{"name":"Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA"},{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Un-In","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Shaffer","sequence":"additional","affiliation":[{"name":"Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Smith","sequence":"additional","affiliation":[{"name":"Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Barnhart","sequence":"additional","affiliation":[{"name":"Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, Cambridge University, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Olivier","sequence":"additional","affiliation":[{"name":"Laboratory of Chronic Airway Infection, Cardiovascular & Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Holland","sequence":"additional","affiliation":[{"name":"Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2025083110462567000_7.1.e000574.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.10.002"},{"key":"2025083110462567000_7.1.e000574.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.05.035"},{"key":"2025083110462567000_7.1.e000574.3","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1513\/AnnalsATS.201605-387WS","article-title":"Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection. An NTM research Consortium workshop report","volume":"13","author":"Henkle","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2025083110462567000_7.1.e000574.4","doi-asserted-by":"publisher","DOI":"10.1586\/ers.12.58"},{"key":"2025083110462567000_7.1.e000574.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1432ED"},{"key":"2025083110462567000_7.1.e000574.6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1333573"},{"key":"2025083110462567000_7.1.e000574.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1035OC"},{"key":"2025083110462567000_7.1.e000574.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1173"},{"key":"2025083110462567000_7.1.e000574.9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201306-1059LE","article-title":"A familial syndrome of pulmonary nontuberculous mycobacteria infections","volume":"188","author":"Leung","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110462567000_7.1.e000574.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0387OC"},{"key":"2025083110462567000_7.1.e000574.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2197OC"},{"key":"2025083110462567000_7.1.e000574.12","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.yexcr.2011.07.007","article-title":"Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells","volume":"317","author":"Jiao","year":"2011","journal-title":"Exp Cell Res"},{"key":"2025083110462567000_7.1.e000574.13","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.111724"},{"key":"2025083110462567000_7.1.e000574.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2008.05.010"},{"key":"2025083110462567000_7.1.e000574.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2025083110462567000_7.1.e000574.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200805-686OC"},{"key":"2025083110462567000_7.1.e000574.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2818.2003.01209.x"},{"key":"2025083110462567000_7.1.e000574.18","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110462567000_7.1.e000574.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2010.08.020"},{"key":"2025083110462567000_7.1.e000574.20","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205887"},{"key":"2025083110462567000_7.1.e000574.21","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9607083"},{"key":"2025083110462567000_7.1.e000574.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R"},{"key":"2025083110462567000_7.1.e000574.23","doi-asserted-by":"publisher","DOI":"10.1080\/00016489950180487"},{"key":"2025083110462567000_7.1.e000574.24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1165\/rcmb.2017-0218OC","article-title":"Transcriptional response of respiratory epithelium to nontuberculous mycobacteria","volume":"58","author":"Matsuyama","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025083110462567000_7.1.e000574.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.02.009"},{"key":"2025083110462567000_7.1.e000574.26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5339\/gcsp.2014.42","article-title":"The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases","volume":"2014","author":"Butrous","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"2025083110462567000_7.1.e000574.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.944603"},{"key":"2025083110462567000_7.1.e000574.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.08.004"},{"key":"2025083110462567000_7.1.e000574.29","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s11136-014-0727-3","article-title":"Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease","volume":"23","author":"Hong","year":"2014","journal-title":"Qual Life Res"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2020-000574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:46:34Z","timestamp":1756662394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2020-000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/bmjresp-2020-000574"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2020-000574","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}